Advanz Pharma says UK competition court erred over ruling on thyroid drug pricing
Advanz Pharma told appeal judges today that the UK competition court handed down a flawed ruling when it supported the Competition and Markets Authority's infringement case against the company over the...To view the full article, register now.
Already a subscriber? Click here to view full article